Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRASTUZUMAB-ANNS for Off label use: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where TRASTUZUMAB-ANNS was used for Off label use.

Most Reported Side Effects for TRASTUZUMAB-ANNS

Side Effect Reports % Deaths Hosp.
Product storage error 346 25.2% 0 0
Circumstance or information capable of leading to medication error 257 18.8% 0 0
Off label use 104 7.6% 3 23
Intercepted product administration error 89 6.5% 0 0
Product dose omission issue 68 5.0% 0 0
Chills 58 4.2% 0 27
Dyspnoea 52 3.8% 1 16
Nausea 49 3.6% 1 10
Diarrhoea 48 3.5% 2 7
Rash 45 3.3% 0 1
Fatigue 42 3.1% 1 3
Intercepted product preparation error 42 3.1% 0 0
Product preparation error 40 2.9% 0 0
Accidental exposure to product 39 2.8% 0 0
Infusion related reaction 34 2.5% 0 2

Other Indications for TRASTUZUMAB-ANNS

Product used for unknown indication (871) Breast cancer (297) Breast cancer metastatic (36) Her2 positive breast cancer (34) Breast cancer female (25) Her-2 positive breast cancer (10) Endometrial cancer (9) Invasive ductal breast carcinoma (8) Gastric cancer (7) Oesophageal carcinoma (7)

Other Drugs Used for Off label use

LENALIDOMIDE (5,767) ECULIZUMAB (3,550) CERTOLIZUMAB PEGOL (2,256) ABOBOTULINUMTOXINA (2,170) LEVETIRACETAM (2,161) APREMILAST (1,995) PROPRANOLOL (1,576) CETIRIZINE (1,416) HUMAN IMMUNOGLOBULIN G (1,129) THALIDOMIDE (1,033)

Related Pages

TRASTUZUMAB-ANNS Full Profile All Off label use Drugs TRASTUZUMAB-ANNS Demographics TRASTUZUMAB-ANNS Timeline